1. Anti-tumor efficacy of a combination therapy with PD-L1 targeted alpha therapy and adoptive cell transfer of PD-1 deficient melanoma-specific human T-lymphocytes. (1st January 2021) Authors: Marotte, L; Capitao, M; Deleine, C; Beauvais, T; Cadiou, G; Perrin, J.; Chérel, M; Scotet, E; Guilloux, Y; Bruchertseifer, F; Morgenstern, A; Jarry, A; Gaschet, J.; Labarriere, N Journal: Oncoimmunology Issue: Volume 10:Number 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗